For 77 years, Windlas family has been in business. Our journey has been exciting and rewarding with a successful track record of different products, customers and teams.

Windlas Biotech was born in year 2000 as the family revived a shutdown manufacturing facility after purchasing the same from financial institutions. Over the past two decades, Windlas has evolved into a fully integrated partner providing products and services to leading pharmaceutical companies. It has also created its own branded products that are distributed through its rapidly growing distribution network of more than 500 wholesalers across India.

2001


Plant 1 established and production started

2007


Set up of own brand (Marketing Division)

2009

Ventured into the International Markets. Crossed Rs 100 Cr revenue
by establishing a Windlas Healthcare plant

2014

Plant 2 set up comissioned and crossed Rs. 200 Cr.
1st USFDA inspection cleared for Windlas Healthcare plant

2015

Received private equity investment from Tano Capital

2016

Crossed Rs. 300 Cr. turnover.

2017

Plant 3 set up completed. Launched 1st product in US from WHC

2018

23 Million Dollar investment from Zydus in WHC

2019


Buyback of Zydus’ share in Windlas Healthcare